These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23650777)

  • 21. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease.
    Guandalini S
    Expert Rev Clin Immunol; 2010 Jan; 6(1):47-54. PubMed ID: 20383890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics in the management of Crohn's disease and ulcerative colitis.
    Müllner K; Miheller P; Herszényi L; Tulassay Z
    Curr Pharm Des; 2014; 20(28):4556-60. PubMed ID: 24180407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics in Inflammatory Bowel Disease.
    Abraham BP; Quigley EMM
    Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics in the Treatment of Inflammatory Bowel Disease.
    Guandalini S; Sansotta N
    Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotics and probiotics in treatment of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
    World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
    Sartor RB
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of inflammatory bowel disease].
    Schölmerich J
    Praxis (Bern 1994); 2007 Feb; 96(9):337-43. PubMed ID: 17361635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's?
    Haag LM; Siegmund B
    Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):399-409. PubMed ID: 24913380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
    Mitsuyama K; Toyonaga A; Sata M
    J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies.
    Colombel JF
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):652-4. PubMed ID: 25311475
    [No Abstract]   [Full Text] [Related]  

  • 34. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics for the treatment of inflammatory bowel disease.
    Veerappan GR; Betteridge J; Young PE
    Curr Gastroenterol Rep; 2012 Aug; 14(4):324-33. PubMed ID: 22581276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal microflora in patients with Crohn's disease and ulcerative colitis.
    Levitan MC; Marco OP
    Am J Proctol; 1976 Dec; 27(6):49-54. PubMed ID: 998773
    [No Abstract]   [Full Text] [Related]  

  • 40. The gut microbiota in inflammatory bowel disease.
    Macfarlane GT; Blackett KL; Nakayama T; Steed H; Macfarlane S
    Curr Pharm Des; 2009; 15(13):1528-36. PubMed ID: 19442170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.